CA-BELKIN
2.2.2024 18:01:30 CET | Business Wire | Press release
Belkin, a leading consumer electronics brand for 40 years, today announced a new division to the company, Future Ventures. This division will focus on opportunities and new avenues for Belkin to explore creative solutions for the modern world including content creation, spatial computing, Artificial Intelligence, robotics, and more. The first two products from this new line are the Auto-Tracking Stand Pro, announced earlier this year at CES 2024, and a new Battery Holder for Apple Vision Pro.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240202187821/en/
The first two products from Belkin Future Ventures division are the Auto-Tracking Stand Pro, announced earlier this year at CES 2024, and a new Battery Holder for Apple Vision Pro. (Photo: Business Wire)
Future Ventures will be comprised of forward-thinking designers, engineers and product managers all in-house at Belkin’s headquarters in El Segundo, CA and in satellite hubs worldwide. Belkin’s longstanding legacy in creating quality and human-centric peripheral mobile and computer accessories is the basis behind this new division, and steadily positions the company for new products and categories for the next generation.
“Belkin has been innovating for over 40 years, and Future Ventures was a clear next step in our plans to continue bringing new ideas to the table,” said Steve Malony, CEO, Belkin. “We know that good ideas come from anywhere, so we are looking everywhere to explore new categories and products that we believe in. Future Ventures opens the door to new markets that Belkin has not typically been part of in previous years. We experienced major success at CES 2024 with our new Auto-Tracking Stand Pro, but this is just the beginning of what this new division is capable of.”
The Auto-Tracking Stand Pro
The world’s first Apple certified Works with DockKit accessory, the Auto-Tracking Stand Pro provides seamless hands-free camerawork for content creators, filmmakers, educators, virtual presenters, social app developers, and more. DockKit’s automated subject tracking technology is designed to follow subjects on camera as they move around their space with 360 degrees of pan and 90 degrees of tilt. Additionally, the Auto-Tracking Stand Pro is made more responsibly with a minimum of 75% PCR materials and sold in plastic-free packaging in line with Belkin’s commitment to find more responsible ways to build products.
The Auto-Tracking Stand Pro is $179.99 USD and is available to pre-order on belkin.com. Media kit is available for download HERE.
Battery Holder for Apple Vision Pro
Designed to keep the Apple Vision Pro Battery secure, the Battery Holder allows for a convenient and versatile hands-free experience. The Battery Holder offers a quick and easy way to clip the battery onto a belt or pants, while the cross-body strap gives those without clip access a great way to secure the battery while using Apple Vision Pro.
The Battery Holder is $49.95 USD and is now available at apple.com. Media kit is available for download HERE.
For more information on Belkin’s products, please visit Belkin.com or follow Belkin on Instagram, Facebook, TikTok, LinkedIn and X.
About Belkin
Belkin is a California-based accessories leader delivering award-winning power, protection, productivity, connectivity, and audio products over the last 40 years. Designed and engineered in Southern California and sold in more than 100 countries around the world, Belkin has maintained its steadfast focus on research and development, community, education, sustainability and most importantly, the people it serves. From our humble beginnings in a Southern California garage in 1983, Belkin has become a diverse, global technology company. We remain forever inspired by the planet we live on, and the connection between people and technology.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240202187821/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom